| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
40,907,602 | 39,447,844 | 35,668,386 | 34,792,557 | 32,476,133 |
| Cost of Revenue
|
-28,086,092 | -26,901,103 | -24,340,697 | -25,057,128 | -24,213,779 |
|
Gross Profit
|
12,821,510 | 12,546,741 | 11,327,689 | 9,735,429 | 8,262,354 |
| Selling, General and Administrative Expenses
|
-4,534,664 | -4,312,246 | -4,252,680 | -4,094,462 | -3,680,986 |
|
Research and Development Expenses
|
-2,084,078 | -2,036,682 | -1,872,891 | -1,674,404 | -1,487,585 |
|
Other Income/Expense, Operating
|
0 | 0 | 0 | 0 | 434 |
|
Operating Income/Expenses
|
-6,618,742 | -6,348,928 | -6,125,571 | -5,768,866 | -5,168,571 |
|
Total Operating Profit/Loss
|
6,202,768 | 6,197,813 | 5,202,118 | 3,966,563 | 3,093,783 |
| Total Net Finance Income/Expense
|
155,209 | 173,271 | 166,710 | 140,127 | 5,849 |
| Net Investment Income
|
129,246 | 209,718 | 202,111 | 293,155 | 127,805 |
|
Other Income/Expense, Non-Operating
|
227,216 | 129,980 | 284,533 | 524,110 | -74,380 |
|
Non-Operating Income/Expenses, Total
|
511,671 | 512,969 | 653,354 | 957,392 | 59,274 |
|
Pretax Income
|
6,714,439 | 6,710,782 | 5,855,472 | 4,923,955 | 3,153,057 |
|
Provision for Income Tax
|
-1,172,915 | -1,246,517 | -1,159,961 | -966,538 | -471,380 |
|
Net Income from Continuing Operations
|
5,541,524 | 5,464,265 | 4,695,511 | 3,957,417 | 2,681,677 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
5,541,524 | 5,464,265 | 4,695,511 | 3,957,417 | 2,681,677 |
|
Non-Controlling/Minority Interests
|
-284,042 | -237,294 | -247,708 | -212,875 | -116,509 |
|
Net Income after Non-Controlling/Minority Interests
|
5,257,482 | 5,226,971 | 4,447,803 | 3,744,542 | 2,565,168 |
|
Net Income Available to Common Stockholders
|
5,257,482 | 5,226,971 | 4,447,803 | 3,744,542 | 2,565,168 |
|
Diluted Net Income Available to Common Stockholders
|
5,257,482 | 5,226,971 | 4,447,803 | 3,744,542 | 2,565,168 |
| Basic EPS
|
8.46 | 8.43 | 7.26 | 6.17 | 4.27 |
| Diluted EPS
|
8.31 | 8.31 | 7.11 | 6.04 | 4.23 |
|
Basic Weighted Average Shares Outstanding
|
621,437.86 | 620,044.01 | 612,645.04 | 606,894.98 | 600,741.92 |
|
Diluted Weighted Average Shares Outstanding
|
633,398.13 | 628,997.71 | 625,570.04 | 619,957.29 | 606,422.70 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
6,559,230 | 6,537,511 | 5,688,762 | 4,783,828 | 3,147,208 |
|
EBITDA
|
7,946,932 | 7,869,819 | 7,026,262 | 6,112,940 | 4,424,589 |
|
Normalized EBITDA
|
7,969,629 | 7,925,815 | 7,007,038 | 5,928,225 | 4,526,125 |
|
Normalized Income
|
5,560,256.17 | 5,509,859.85 | 4,680,095.26 | 3,808,960.26 | 2,768,033.47 |
|
Total Unusual Items
|
22,697 | 55,996 | -19,224 | -184,715 | 101,536 |
12/31/2022 - 2/26/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade